Procurement of Essential Hemato-Oncology Drugs for ESIC Facilities

This tender, identified by Bid Number GEM/2026/B/8044118, is issued by the Employees State Insurance Corporation, operating under the Ministry of Labour and Employment. The tender, dated 03-10-2026, pertains to the procurement of essential hemato-oncology drugs, as detailed in the Bill of Quantities (BOQ) titled "nrc hematooncology drugs." The bidding period commences on 03-10-2026 at 12:38 PM and concludes on 24-10-2026 at 1:00 PM. The specified office for this tender is Hyderabad. The scope of supply encompasses a comprehensive list of critical pharmaceutical items, including but not limited to: Injection Plerixafor, Injection Carmustine, Injection Gancyclovir, Injection Aztreonam, Injection Voriconazole, Syrup Posaconazole, Capsule Aprepitant Kit, Injection Cyclophosphamide (200 mg), Injection Dactinomycin (0.5 mg), Injection Eribulin (0.88 mg), Injection Mesna (200 mg), Injection Methotrexate (15 mg), Injection Vincristine (1 mg), Injection Vinblastine (10 mg), and Injection Methotrexate (500 mg). The total quantity of these items required is 615 units across the various listed drugs. This tender represents a significant opportunity for suppliers to provide vital medications for hemato-oncology treatments within the Employees State Insurance Corporation's facilities.